Studying dantrolene for statin-related muscle pain
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This trial tests whether dantrolene can relieve muscle pain or weakness caused by statin medications. If you have muscle symptoms and high creatine kinase levels, this study may help find a treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been taking a statin medicine for at least 4 weeks and have muscle pain or weakness.
- Your blood test shows a muscle enzyme (creatine kinase) level at least 1.5 times the normal upper limit.
- You are willing to stop your statin during the study if needed.
- You do not have severe liver disease, severe kidney disease, or a neuromuscular disorder like ALS or muscular dystrophy.
- You are not pregnant, breastfeeding, or taking certain medications like verapamil that could interact with dantrolene.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests whether an annatto-derived product (called GG) can help people who develop new muscle pain after starting or increasing a statin. If you recently noticed statin-related muscle aches, this study may see whether the treatment improves symptoms and safety.
This trial tests whether adding metoprolol (a beta-blocker) to usual care can prevent or slow cardiomyopathy (heart muscle weakness) in people with Duchenne muscular dystrophy (DMD). It also checks for safety, especially effects on heart rate and rhythm.
This early-stage study tests DYNE-101 to see how safe it is and whether it can improve measurable muscle function in people with myotonic dystrophy type 1 (DM1). You may be asked to do several walking and strength tests and undergo heart and breathing screening measurements.
This study tests whether a new medicine called zeleciment rostudirsen can help ambulatory (walking) males with Duchenne muscular dystrophy (DMD). The medicine is given as an intravenous infusion (through a vein) every 4 weeks and works by helping the body produce a protective muscle protein.
This trial tests a once-daily drug called mexiletine PR to see if it can help reduce muscle stiffness (myotonia) in people with myotonic dystrophy type 1 or 2. It may be a good option if you have a confirmed genetic diagnosis and are at least 16 years old.
This trial tests an experimental drug called DYNE-101 to see if it can help people with myotonic dystrophy type 1 (DM1). The study aims to improve muscle function and daily life. It is for adults who can walk and stand up from a chair without help.
Hear when a new Statins Induced Myopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.